Format

Send to

Choose Destination
Leukemia. 2016 Jan;30(1):242-7. doi: 10.1038/leu.2015.122. Epub 2015 May 15.

Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment.

Author information

1
Department of Medical Oncology, Comenius University, Faculty of Medicine, St Elizabeth Cancer Institute, Bratislava, Slovak Republic.
2
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
3
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
4
Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
5
Second Department of Medical Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovak Republic.
6
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
7
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
PMID:
25975189
DOI:
10.1038/leu.2015.122
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center